Report of a vagal paraganglioma at the cervicothoracic junction.
Male
Humans
Aged
Gallium Radioisotopes
Positron Emission Tomography Computed Tomography
Vagus Nerve
/ surgery
Paraganglioma, Extra-Adrenal
/ diagnostic imaging
Cranial Nerve Neoplasms
/ diagnostic imaging
Vagus Nerve Diseases
/ diagnostic imaging
Head and Neck Neoplasms
/ pathology
Paraganglioma
/ diagnostic imaging
glomus vagale
intrathoracic extension
neck mass
paraganglioma
sternotomy
vagus nerve
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
15
05
2023
received:
17
02
2023
accepted:
27
07
2023
medline:
25
9
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
ppublish
Résumé
Vagus nerve paragangliomas are rare tumors, comprising 0.03% of head and neck neoplasms. These tumors are usually located cephalad to the hyoid bone, and there is only one previously reported case that arose from the lower third of the neck. We describe the second reported case of a lower neck vagus nerve paraganglioma that was managed with a limited sternotomy for access and surgical removal. A 66-year-old male presented with a long-standing lesion of the cervicothoracic junction. CT, MRI, and Ga-68 DOTATATE PET/CT showed an avidly enhancing 5.2 × 4.2 × 11.5 cm mass extending from C6 to approximately T4 level. FNA confirmed the diagnosis. The patient underwent catheter angiography and embolization via direct puncture technique followed by excision of the mass via a combined transcervical and limited sternotomy approach. We describe an unusual case of vagal paraganglioma at the cervicothoracic junction with retrosternal extension requiring a sternotomy for surgical excision.
Sections du résumé
BACKGROUND
Vagus nerve paragangliomas are rare tumors, comprising 0.03% of head and neck neoplasms. These tumors are usually located cephalad to the hyoid bone, and there is only one previously reported case that arose from the lower third of the neck.
METHODS
We describe the second reported case of a lower neck vagus nerve paraganglioma that was managed with a limited sternotomy for access and surgical removal.
RESULTS
A 66-year-old male presented with a long-standing lesion of the cervicothoracic junction. CT, MRI, and Ga-68 DOTATATE PET/CT showed an avidly enhancing 5.2 × 4.2 × 11.5 cm mass extending from C6 to approximately T4 level. FNA confirmed the diagnosis. The patient underwent catheter angiography and embolization via direct puncture technique followed by excision of the mass via a combined transcervical and limited sternotomy approach.
CONCLUSION
We describe an unusual case of vagal paraganglioma at the cervicothoracic junction with retrosternal extension requiring a sternotomy for surgical excision.
Substances chimiques
Gallium-68
98B30EPP5S
Gallium Radioisotopes
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
E36-E43Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Boedeker CC. Paragangliomas and paraganglioma syndromes. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc03.
Varoquaux A, Kebebew E, Sebag F, et al. Endocrine tumors associated with the vagus nerve. Endocr Relat Cancer. 2016;23(9):R371-R379.
Boedeker CC, Ridder GJ, Schipper J. Paragangliomas of the head and neck: diagnosis and treatment. Fam Cancer. 2005;4(1):55-59.
Lozano FS, Gómez JL, Mondillo MC, González-Porras JR, González-Sarmiento R, Muñoz A. Surgery of vagal paragangliomas: six patients and review of literature. Surg Oncol. 2008;17(4):281-287.
Singh S, Madan R, Singh MK, Thakar A, Sharma SC. Head-and-neck paragangliomas: an overview of 54 cases operated at a tertiary care center. South Asian J Cancer. 2019;8(4):237-240.
Ahmed Y, Arif A, Manzoor Bhatti A, et al. Vagal paraganglioma: a rare finding in a 31-year-old male. Curēus (Palo Alto, CA). 2021;13(10).
Mendenhall WM, Amdur RJ, Vaysberg M, Mendenhall CM, Werning JW. Head and neck paragangliomas. Head Neck. 2011;33(10):1530-1534.
Moore MG, Netterville JL, Mendenhall WM, Isaacson B, Nussenbaum B. Head and neck paragangliomas: an update on evaluation and management. Otolaryngol Head Neck Surg. 2016;154(4):597-605.
Lin EP, Chin BB, Fishbein L, et al. Head and neck paragangliomas: an update on the molecular classification, state-of-the-art imaging, and management recommendations. Radiol Imaging Cancer. 2022;4(3):e210088.
Groblewski JC, Thekdi A, Carrau RL. Secreting vagal paraganglioma. Am J Otolaryngol. 2004;25(4):295-300.
van Nederveen FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009;10(8):764-771.
Choi YJ, Yang KH, Gang SJ, Kim BK, Kim SM. Malignant glomus tumor originating in the superior mediastinum: an immunohistochemical and ultrastructural study. J Korean Med Sci. 1991;6(2):157-163.
Gaertner EM, Steinberg DM, Huber M, et al. Pulmonary and mediastinal glomus tumors-report of five cases including a pulmonary glomangiosarcoma: a clinicopathologic study with literature review. Am J Surg Pathol. 2000;24(8):1105-1114.
Bali GS, Hartman DJ, Haight JB, Gibson MK. A rare case of malignant glomus tumor of the esophagus. Case Rep Oncol Med. 2013;2013:287078.
Rychlik IJ, O'Donnell ME, Davey P, Merard R, McGuigan J. Glomus tumor of the mediastinum. Asian Cardiovasc Thorac Ann. 2014;22(1):95-97.
Jang SH, Cho HD, Lee JH, et al. Mediastinal glomus tumor: a case report and literature review. J Pathol Transl Med. 2015;49(6):520-524.
Kanakis M, Rapti N, Chorti M, Lioulias A. Asymptomatic glomus tumor of the mediastinum. Case Rep Surg. 2015;2015:631625.
Majewska A, Budny B, Ziemnicka K, Ruchała M, Wierzbicka M. Head and neck paragangliomas-a genetic overview. Int J Mol Sci. 2020;21(20):7669.
Hu K, Persky MS. Treatment of head and neck paragangliomas. Cancer Control. 2016;23(3):228-241.
Myssiorek D. Head and neck paragangliomas: an overview. Otolaryngol Clin North Am. 2001;34(5):829-836.
Tsirlin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA. Pheochromocytoma: a review. Maturitas. 2014;77(3):229-238.
Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med. 1999;340(24):1872-1879.
Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? Jama. 2002;287(11):1427-1434.
Eisenhofer G, Peitzsch M. Laboratory evaluation of pheochromocytoma and paraganglioma. Clin Chem. 2014;60(12):1486-1499.
Shen Y, Cheng L. Biochemical diagnosis of pheochromocytoma and paraganglioma. In: Mariani-Costantini R, ed. Paraganglioma: A Multidisciplinary Approach. Codon Publications; 2019.
Netterville JL, Jackson CG, Miller FR, Wanamaker JR, Glasscock ME. Vagal paraganglioma: a review of 46 patients treated during a 20-year period. Arch Otolaryngol Head Neck Surg. 1998;124(10):1133-1140.
Janssen I, Chen CC, Taieb D, et al. 68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT/MRI. J Nucl Med. 2016;57(2):186-191.
Mediouni A, Ammari S, Wassef M, et al. Malignant head/neck paragangliomas. Comparative study. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131(3):159-166.
Wachtel H, Fishbein L. Genetics of pheochromocytoma and paraganglioma. Curr Opin Endocrinol Diabetes Obes. 2021;28(3):283-290.
Pollard PJ, Wortham NC, Tomlinson IP. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Ann Med. 2003;35(8):632-639.
Selak MA, Armour SM, MacKenzie ED, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 2005;7(1):77-85.
Jochmanova I, Wolf KI, King KS, et al. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations. J Cancer Res Clin Oncol. 2017;143(8):1421-1435.
Andrews KA, Ascher DB, Pires DEV, et al. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD. J Med Genet. 2018;55(6):384-394.
Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol. 2005;23(34):8812-8818.
Boedeker CC, Hensen EF, Neumann HP, et al. Genetics of hereditary head and neck paragangliomas. Head Neck. 2014;36(6):907-916.
Mottie L, Meulemans J, Vander PV. Vagal paragangliomas. Curr Opin Otolaryngol Head Neck Surg. 2023;31(2):146-154.
Sandow L, Thawani R, Kim MS, Heinrich MC. Paraganglioma of the head and neck: a review. Endocr Pract. 2023;29(2):141-147.
Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Antonelli PJ, Cassisi NJ. Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body, and glomus vagale. Head Neck. 2001;23(5):363-371.
Suárez C, Rodrigo JP, Bödeker CC, et al. Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy. Head Neck. 2013;35(8):1195-1204.
Cohen SM, Burkey BB, Netterville JL. Surgical management of parapharyngeal space masses. Head Neck. 2005;27(8):669-675.
González-Orús Álvarez-Morujo R, Arístegui Ruiz M, Martin Oviedo C, Álvarez Palacios I, Scola YB. Management of vagal paragangliomas: review of 17 patients. Eur Arch Otorhinolaryngol. 2015;272(9):2403-2414.
Elhammady MS, Peterson EC, Johnson JN, Aziz-Sultan MA. Preoperative Onyx embolization of vascular head and neck tumors by direct puncture. World Neurosurg. 2012;77(5-6):725-730.
Prasad SC, Paties CT, Pantalone MR, Mariani-Costantini R, Sanna M. Carotid body and vagal paragangliomas: epidemiology, genetics, clinicopathological features, imaging, and surgical management. In: Mariani-Costantini R, ed. Paraganglioma: A Multidisciplinary Approach. Codon Publications; 2019.
Michelozzi C, Januel AC, Cuvinciuc V, et al. Arterial embolization with Onyx of head and neck paragangliomas. J Neurointerv Surg. 2016;8(6):626-635.
Schmalbach CE, Gourin C. Managing vascular tumors-open approaches. Otolaryngol Clin North Am. 2016;49(3):777-790.